Priority Medical

BIDEN-ADMINISTRATION

How ‘green’ inhalers could evade Biden’s drug pricing legacy
BIDEN-ADMINISTRATION

How ‘green’ inhalers could evade Biden’s drug pricing legacy

Introduction In a significant push to reduce healthcare costs and improve accessibility to essential medications, the Biden administration has implemented various reforms to combat high prescription drug prices. These efforts include reformed Medicare, aggressive challenges to bogus drug patents, and efforts to push pharmaceutical companies to reduce inhaler costs for patients..

No more articles to show